Behar Gregory is a director of Seres Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Seres Therapeutics, Inc.
23 Jun 23
4
Seres Therapeutics, Inc.
24 Jun 22
4
Seres Therapeutics, Inc.
21 Jun 21
4
Axcella Health Inc.
24 May 21
4
Aimmune Therapeutics, Inc.
14 Oct 20
4
Seres Therapeutics, Inc.
22 Jun 20
4
Aimmune Therapeutics, Inc.
29 May 20
4
Axcella Health Inc.
22 May 20
4
Seres Therapeutics, Inc.
14 Jun 19
4
Aimmune Therapeutics, Inc.
28 May 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jun 23 | MCRB Seres Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.46 | 35,000 | 191.10 k | 35,000 |